Cargando…
小细胞肺癌免疫治疗的临床研究进展
Small cell lung cancer (SCLC) is a "refractory cancer" characterized by rapid growth and extensive early metastasis. About 70% of patients are already in the extensive stage at the time of diagnosis. Despite the high response rate to platinum-contained first-line chemotherapy, almost all p...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679219/ https://www.ncbi.nlm.nih.gov/pubmed/32752583 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.105.02 |